Safety and efficacy of neuromuscular electrical stimulation for inpatients with cardiovascular disease

Safety and efficacy of neuromuscular electrical stimulation for inpatients with cardiovascular disease - Safety and efficacy of neuromuscular electrical stimulation for inpatients with cardiovascular disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014196

Enrollment

Registered

2014-06-07

Start date

2013-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Neuromuscular electrical stimulation of the highest tolerable intensity Neuromuscular electrical stimulation of the minimum intensity that did not induce muscle contractions

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with cardiovascular disease are undergoing cardiac rehabilitation

Exclusion criteria

Exclusion criteria: 1.Patients with unstable angina pectoris 2.Patients with uncontrolled decompensated heart failure 3.Patients who used pacemaker 4.Patients who are not allowed to receive neuromuscular electrical stimulation

Design outcomes

Primary

Measure	Time frame
Vascular endothelial function	—

Secondary

Measure	Time frame
Blood pressure, heart rate, stroke volume, cardiac output, cardiac index, systemic vascular resistance, sympathetic activity, transcutaneous oxygen pressure	—

Countries

Japan

Contacts

Public ContactTANAKA SHINYA

Kitasato University Graduate School of Medical Sciences

tanashin.pt@gmail.com042-778-9081

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026